Human genome project. Variation is now the theme.

P. Goodfellow

IF: 64.8

Nature

Abstract:

What problem does this paper attempt to address?

Relative Risk of Gastric Cancer Between Those with and Without Helicobacter Pylori Infection History in Japan

Shogo Kikuchi,Yuki Obata,Tae Sasakabe,Sayo Kawai,Chaochen Wang,Yingsong Lin

DOI: https://doi.org/10.1002/jgh3.12714

2022-01-01

JGH Open

Abstract:Background and Aim: The causal relationship between Helicobacter pylori (H. pylori) infection and gastric cancer has been established. Although the magnitude of the carcinogenic effect of H. pylori is the next concern, it has not been sufficiently evaluated in Japan. Spontaneous disappearance of H. pylori infection may have provoked underestimation of the carcinogenic effect of the infection. To reduce the influence, a comparison should be carried out between subjects with and without the infection history. Cutoff values of H. pylori antibody lower than the manufacturer's recommendation are known to be more appropriate to diagnose history of H. pylori infection. The aim was to evaluate the carcinogenic effect of H. pylori. Methods: A case-control study consisting of 275 gastric cancer patients and 275 age- and sex-matched controls was performed. Serum H. pylori antibody was measured using the "JHM-Cap" kit with a domestic antigen (cut value of the manufacturer's recommendation was 2.3 EV: ELISA value). Using a conditional logistic model, the odds ratios (ORs) for five cutoff values adjusted for smoking and drinking doses were calculated. Results: For cutoff values of 1.25, 1.5, 1.75, 2.0, and 2.3 EV, the ORs (95% confidence intervals) were 67.7 (9.1, 502), 37.2 (8.8, 157), 21.3 (9.0, 60.2), 25.5 (9.0, 72.7), and 25.9 (9.2, 73.2), respectively. Conclusions: These results suggest that the risk ratio of gastric cancer between subjects with and without history of H. pylori infection in Japan may exceed 20.
A novel predictive formula for highly accurate discrimination between truly Helicobacter pylori-uninfected and currently infected/spontaneously eradicated individuals for gastric cancer screening

Takako Takayama,Hideo Suzuki,Kosuke Okada,Shintaro Akiyama,Toshiaki Narasaka,Kazushi Maruo,Taku Sakamoto,Emiko Seo,Kiichiro Tsuchiya

DOI: https://doi.org/10.1097/md.0000000000036335

IF: 1.6

2024-03-13

Medicine

Abstract:The ABC classification, based on Helicobacter pylori (H pylori ) antibody titer detected via enzyme-linked immunosorbent assay (ELISA) and serum pepsinogen (PG) levels, is a valuable tool for distinguishing gastric cancer risk profiles. [ 1 , 2 ] This method requires categorization of the subjects into 4 groups: Group A ( H pylori antibody [−], PG [−]), Group B ( H pylori antibody [+], PG [−]), Group C ( H pylori antibody [+], PG [+]), and Group D ( H pylori antibody [−], PG [+]). Groups B, C, and D were reported to have higher gastric cancer risks compared to Group A. [ 3–5 ] However, the ABC classification carries false-negative possibilities in high-risk individuals who have been infected and experienced spontaneous eradication but are included in Group A. [ 6–8 ] Another problem is that, although cutoffs for H pylori antibody values based on ELISA for gastric cancer screening were previously determined as < 3 U/mL, cutoff values for the latex immunoassay (LIA) method, which has recently become widely used, are not yet established. According to the manufacturer instructions, the recommended cutoff value of 10 U/mL for the LZ test (Eiken Chemical Co., Ltd., Tokyo, Japan) based on the LIA method was determined through an assessment of the outcomes from urea breath tests, with the aim of identifying a currently infected status. Therefore, we need to identify another cutoff value for gastric cancer screening. To detect high-risk individuals, including spontaneously eradicated status individuals, Inoue et al identified the cutoff value for this population (currently infected + previously infected [excluding post eradication]) versus the truly uninfected (determined by the LZ test) as 5.2 U/mL [ 9 ] while our previous study of 2 different populations reported values of 3 U/mL and < 3 U/mL, respectively. [ 10 , 11 ] It is essential to discriminate truly low-risk, uninfected individuals from currently infected/spontaneously eradicated cases who require endoscopy because of high gastric cancer risk.

medicine, general & internal
[Serological Assessment of Helicobacter Pylori-Specific Antibodies and Their Association with Gastric Lesions in a High-Risk Population].

Cong Liu,Yu-mei Wang,Zhe-xuan Li,Lian Zhang,Jun-ling Ma,Tong Zhou,Wei-cheng You,Kai-feng Pan

DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2013.07.016

2013-01-01

Abstract:OBJECTIVE:To determine the distributions of six Helicobacter pylori (Hp)-specific antibodies in a high-risk population of gastric cancer (GC) and explore the relationship between Hp virulence factors and precancerous gastric lesions.METHODS:Based on the two intervention trials conducted in Linqu County, the seropositivities for CagA, VacA, GroEL, UreA, HcpC and GGT were assessed by recombinant immunoassay (recomLine) in 623 participants with H. pylori infection determined by (13)C-urea breath test ((13)C-UBT) and/or enzyme linked immunosorbent assay (ELISA).RESULTS:In a total of 623 participants were detected by recomLine analysis, of which 594 were Hp-positive. The seropositivities rates of CagA, VacA, GroEL, UreA, HcpC and GGT were 84.0%, 38.2%, 66.7%, 17.7%, 58.8% and 42.8%, respectively. A total of 523 participants were determined as type I infection of Hp, accounting for 88.1%. Compared with superficial gastritis (SG), the infection rate of Hp type I was higher in the chronic atrophic gastritis (CAG) (P = 0.001).CONCLUSIONS:The results of this population-based study suggest that the virulence factors of Hp may be related to the development of GC in a Chinese high-risk population. The recomLine analysis may serve as a tool for identification of Hp strains and prediction of high-risk population of GC.
Endoscopic and Pathological Characteristics of Helicobacter pylori Infection-Negative Early Gastric Cancer

Taku Mizutani,Hiroshi Araki,Chiemi Saigo,Jun Takada,Masaya Kubota,Takashi Ibuka,Natsuko Suzui,Tatsuhiko Miyazaki,Masahito Shimizu

DOI: https://doi.org/10.1159/000506120

Abstract:Background: The characteristics of Helicobacter pylori (HP) infection-negative gastric cancer (HPINGC) have not been well documented because of the rareness. The aim of this study was to classify HPINGC endoscopically and clinicopathologically. Methods: This retrospective study included 1,741 early gastric cancer lesions and evaluated their HP infection status. Expression levels of MUC5AC, MUC6, MUC2, CD10, p53, MIB-1, pepsinogen-I, H+/K+ ATPase, chromogranin A, E-cadherin, and gastrin were evaluated in tumors by immunohistochemistry (IHC). Results: Among the analyzed lesions, 19 (1.1%) were diagnosed as HPINGC and classified into 6 types: undifferentiated (5 lesions), fundic gland (2 lesions), cardiac gland (1 lesion), pyloric gland (3 lesions), foveolar (5 lesions), and mixed (3 lesions) types. Undifferentiated lesions were of pale color, with unclear demarcation and decreased E-cadherin expression. Fundic-type lesions were tan to reddish in color, with submucosal tumor-like protrusions, and positive for pepsinogen-I and H+/K+ ATPase. The cardiac gland type was located in the gastroesophageal junction and was positive for MUC6 and pepsinogen-I. Pyloric gland-type lesions were of the same color as normal mucosa, with mild elevation and unclear demarcation, likely positive for CD10 and chromogranin A. Foveolar epithelial-type lesions were white and elevated, with defined demarcation, and contained MUC5AC-positive cells. Mixed-type lesions, showing various staining patterns in IHC, had both elevated and depressed shape and reddish color. Conclusion: Endoscopic observation and IHC were useful for classifying the characteristics of HPINGC, which may preserve the characteristics of its region of origin.
Fourier Analysis of Boolean functions and Discrete Isoperimetry

G. Kalai

Abstract:In this talk I will describe recent results and open problems concerning Fourier analysis of boolean functions and applications to combinatorics, probability and theoretical computer science. Of particular interest is the relation with discrete isoperimetric inequalities. I will present a result with Friedgut and Naor on the ”stability” of the edge-isoperimetric inequality (total influence) and some subsequent developments, and a conjecture of Jeff Kahn and myself on the total influence of sets with tiny measure. The known techniques seems helpless when we deal with sets of tiny measure.
Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population

Hao-Lei Cai,Yu-Ling Tong

DOI: https://doi.org/10.12998/wjcc.v9.i31.9431

2021-11-06

Abstract:Background: Atrophic gastritis is a precancerous lesion of the stomach. It has been reported that pepsinogen (PG) can reflect the morphology and function of the gastric mucosa, and it is therefore used as a marker for the early diagnosis of atrophic gastritis. Aim: To evaluate the diagnostic value of serum PG for degree of gastric mucosal atrophy in asymptomatic Chinese upon physical examination. Methods: Medical data were collected from subjects who underwent transnasal gastroscopy between October 2016 and October 2018. For each study subject, serum PG levels and presence of Helicobacter pylori (H. pylori) infection were investigated. Pathology was evaluated using the Operative Link for Gastritis Assessment (OLGA) classification and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) systems. All statistical analyses were carried out using SPSS statistical software. Results: A total of 2256 subjects were enrolled and 1922 cases were finally included in the study. Based on the OLGA grading system, the levels of PGI were slightly decreased, while those of PGII were slightly increased. The PGI/PGII ratio (PGR) was reduced with increasing atrophy. The association between PG and OLGA grading was higher compared with that between PG and the OLGIM grading system. Compared with the OLGA-0 group, a statistically significant difference was observed in the mean age of OLGA-I, III, and IV groups (P < 0.05). In the H. pylori-positive subjects, the PGR levels were notably lower in the OLGA-I, II, and III groups compared with the OLGA-0 group (P < 0.05). H. pylori-positive subjects exhibited significantly higher PGI and PGII serum levels and a significantly lower PGR compared with H. pylori-negative patients in different OLGA groups (P < 0.05). Conclusion: Serum PG levels may represent a non-invasive screening marker for gastric mucosal atrophy in asymptomatic subjects.
Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection

Shogo Kikuchi,Mototsugu Kato,Katsuhiro Mabe,Takashi Kawai,Takahisa Furuta,Kazuhiko Inoue,Masanori Ito,Masaharu Yoshihara,Masaaki Kodama,Kazunari Murakami

DOI: https://doi.org/10.2188/jea.JE20170094

2019-04-05

Abstract:Background: Practical criteria for the use of serum pepsinogen (PG) values in diagnosing Helicobacter pylori infection have not yet been determined. Methods: The results of gastric endoscopies, H. pylori infection tests, and PG values were retrospectively reviewed. Subjects were assigned to groups, including never-infected (with neither infection nor gastric mucosal atrophy), infected (with atrophy or findings indicating infection in endoscopy and positive infection tests except for antibody tests), and ex-infected (with gastric mucosal atrophy and negative infection tests, except for antibody tests). The optimal criteria with combined use of the PG II concentrations and the PG I/PG II ratio were investigated separately for PG measurements obtained with the chemiluminescent magnetic particle immunoassay (CLIA) and latex agglutination (LA) methods, such that the specificity was greater than 70% and the sensitivity was no less than 95% among the never-infected and infected subjects. Similar analyses were performed by combining the data from ex-infected and infected subjects. Results: For the CLIA (LA) method, the optimal criterion among 349 (397) never-infected and 748 (863) infected subjects was a PG II value of at least 10 (12) ng/mL or a PG I/PG II ratio no more than 5.0 (4.0), which produced 96.3% (95.1%) sensitivity and 82.8% (72.8%) specificity. When 172 (236) ex-infected subjects were included, the optimal criterion was the same, and the sensitivity was 89.1% (86.9%). Conclusions: The above criteria may be practical for clinical use, and PG tests using these criteria might prevent unnecessary endoscopic examinations for never-infected subjects.
Serum pepsinogens can help to discriminate between H. pylori-induced and auto-immune atrophic gastritis: Results from a prospective multicenter study

Nicolas Chapelle,Jérôme Martin,Malgorzata Osmola,Caroline Hémont,Maxime Leroy,Marie-Anne Vibet,David Tougeron,Driffa Moussata,Dominique Lamarque,Edith Bigot-Corbel,Damien Masson,Justine Blin,Régis Josien,Jean-François Mosnier,Tamara Matysiak-Budnik

DOI: https://doi.org/10.1016/j.dld.2023.03.015

Abstract:Background: Serum pepsinogen (PG) testing is recommended by the European guidelines for diagnosis of chronic atrophic gastritis (CAG). However, wide variations in diagnostic performances are observed, due to the differences in the extent of gastric atrophy, and possibly in its origin (Helicobacter pylori-, autoimmune (AIG)). Aim: To analyze the diagnostic performances of PGs testing according to these different parameters, using enzyme-linked-immunosorbent serologic assay (ELISA) and chemiluminescent immunoassay (CLEIA). Methods: Serum samples from patients having undergone gastroscopy with biopsies in five French centers were collected prospectively. Sensitivity (Se), specificity (Sp), and Area Under Curve were analyzed according to the extent and origin of CAG. Results: Overall, 344 patients (156 males [45%]; mean age 58.8 [±14.2] years) were included, among whom 44 had AIG. Diagnostic performances of PG I for the detection of corpus CAG were excellent, with Se and Sp of 92.7% and 99.1% for ELISA and 90.5% and 98.2% for CLEIA, respectively. For AIG, corresponding values were 97.7% and 97.4% for ELISA, and 95.6% and 97.1% for CLEIA. In multivariate analysis, PG levels were associated with the auto-immune origin (p<0.001) but not with the extent of the atrophic gastritis. Conclusions: Pepsinogens are highly efficient for the diagnosis of corpus-limited CAG and allow to discriminate AIG from H. pylori-induced gastritis.
Clinical trial of glycodiazine--a new oral hypoglycemic drug.

S. Eisenberg,A. Cohen

Abstract:
A simple hygrometer for the measurement of evaporative loss from rodent skin.

P. Y. Wang,D. Evans,N. Samji,E. Llewellyn-Thomas

DOI: https://doi.org/10.1016/0022-4804(80)90160-2

IF: 2.417

1980-02-01

Journal of Surgical Research

Abstract:
Determination of serum pepsinogens levels in elderly patients with chronic gastritis and its significance

季霞,蔡建庭

2015-01-01

Abstract:Objective To investigate the serum levels of pepsinogen (PG)ⅠandⅡ in elderly patients with chronic gas-tritis and its clinical significance. Methods One hundred and twenty patients with chronic gastritis aged over 70y, including 60 cases of atrophic gastritis and 60 of non- atrophic gastritis were enrol ed in the study as elderly group, 120 patients aged 20~60y, including 60 cases of atrophic gastritis and 60 of non- atrophic gastritis served as control group. Serum PGⅠand PGⅡ levels were measured and the ratio of PGⅠ/PGⅡ (PGR) was calculated. Results There were different significance of PGⅠand PGR between non- atrophic chronic gastritis patients and atrophic chronic gastritis patients in control group. While in case group, the PGⅠand PGR levels in non- atrophic chronic gastritis patients were lower than that of atrophic chronic gastritis patients(P<0.05). The PGⅠand PGR levels in case group were lower than that of control group (P<0.05). According to ROC cure, the cut- off of PGⅠand PGR was 97.25μg/L and 6.75 respectively in chronic gastritis patients over 70 years old. Conclusion Serum PG mea-surement could be used to screen elder chronic atrophic gastritis patients. And its medical reference change should be further explored.
Abstract C13: Population-based Evaluation of Serum Pepsinogen, Anti-H. Pylori IgG Antibody and Gastrin-17 Tests for Gastric Cancer Screening

Huakang Tu,Liping Sun,Yuehua Gong,Qian Xu,Qi Long,Roberd Bostick,Yuan

DOI: https://doi.org/10.1158/1940-6215.prev-13-c13

2013-01-01

Cancer Prevention Research

Abstract:Abstract Objective: This study evaluated the role of multiple serological tests (including serum pepsinogen I (PGI), PGII, PGI/II ratio, anti-H. pylori IgG antibody, and gastrin-17 tests) individually and in combination in gastric cancer (GC) screening. Design: Data were from the Zhuanghe Gastric Cancer Study, a 15-year, population-based endoscopic, gastric diseases screening program in northern China. From 1997 to 2011, esophagogastroduodenoscopies with gastric mucosal biopsies were conducted on 10,693 participants. All serum biomarkers were measured using ELISA, and gastric biopsies were evaluated using standardized criteria. Logistic regression was used to calculate odds ratios (OR) with 95 percent confidence intervals (95% CI) and produce receiver operator characteristic (ROC) curves with corresponding c statistics. In addition, results were replicated in an independent hospital-based population. Results: PGI/II ratio monotonically decreased as gastric mucosa progresses from normal mucosa to precancerous conditions, and to GC, and a low PGI/II ratio (≥ 6.6) was associated with an increased risk of prevalent GC (OR = 2.34, 95% CI: 1.62, 3.39). PGI/II ratio individually or in combination with PGI, PGII, anti-H. pylori IgG antibody and gastrin-17 provided the same c statistic of 0.62 for screening for GC. PGI, PGII, anti-H. pylori IgG antibody or gastrin-17 tests individually provided c statistics less than or equal to 0.55. For identifying abnormal gastric conditions including GC, the five serological tests in combination provided adequate discriminatory performance (c = 0.77), and yielded a sensitivity of 84.0% and specificity of 50.0%. The results from the independent hospital-based population were similar. Conclusion: Our results suggest that serum PGI, PGII, PGI/II ratio, anti-H. pylori IgG and gastrin-17 tests can be used as prescreening tests for patients at high risk for GC. Citation Format: Huakang Tu, Liping Sun, Yuehua Gong, Qian Xu, Qi Long, Roberd Bostick, Yuan Yuan. Population-based evaluation of serum pepsinogen, anti-H. pylori IgG antibody and gastrin-17 tests for gastric cancer screening. [abstract]. In: Proceedings of the Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2013 Oct 27-30; National Harbor, MD. Philadelphia (PA): AACR; Can Prev Res 2013;6(11 Suppl): Abstract nr C13.
Non-parallel coevolution of sender and receiver in the acoustic communication system of treefrogs

J. Schul,Sarah L. Bush

DOI: https://doi.org/10.1098/rspb.2002.2092

2002-09-07

Proceedings of the Royal Society of London. Series B: Biological Sciences

Abstract:Advertisement calls of closely related species often differ in quantitative features such as the repetition rate of signal units. These differences are important in species recognition. Current models of signal–receiver coevolution predict two possible patterns in the evolution of the mechanism used by receivers to recognize the call: (i) classical sexual selection models (Fisher process, good genes/indirect benefits, direct benefits models) predict that close relatives use qualitatively similar signal recognition mechanisms tuned to different values of a call parameter; and (ii) receiver bias models (hidden preference, pre–existing bias models) predict that if different signal recognition mechanisms are used by sibling species, evidence of an ancestral mechanism will persist in the derived species, and evidence of a pre–existing bias will be detectable in the ancestral species. We describe qualitatively different call recognition mechanisms in sibling species of treefrogs. Whereas Hyla chrysoscelis uses pulse rate to recognize male calls, Hyla versicolor uses absolute measurements of pulse duration and interval duration. We found no evidence of either hidden preferences or pre–existing biases. The results are compared with similar data from katydids (Tettigonia sp.). In both taxa, the data are not adequately explained by current models of signal–receiver coevolution.
Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection

Gholam Reza Sivandzadeh,Saeid Amiri Zadeh Fard,Abbas Zahmatkesh,Mohammad Hossein Anbardar,Kamran B Lankarani

DOI: https://doi.org/10.34172/mejdd.2023.318

Abstract:Background: Gastric cancer is one of the most common types of cancer worldwide. Helicobacter pylori infection is clearly correlated with gastric carcinogenesis. Therefore, the use of a new non-invasive test, known as the GastroPanel test, can be very helpful to identify patients at a high risk, including those with atrophic gastritis, intestinal metaplasia, and dysplasia. This study aimed to compare the results of GastroPanel test with the pathological findings of patients with gastric atrophy to find a safe and simple alternative for endoscopy and biopsy as invasive methods. Methods: This cross-sectional study was performed on patients with indigestion, who were referred to Motahari Clinic and Shahid Faghihi Hospital of Shiraz, Iran, since April 2017 until August 2017 for endoscopy of the upper gastrointestinal tract. The serum levels of gastrin-17 (G17), pepsinogen I (PGI), and pepsinogen II (PGII), as well as H. pylori antibody IgG, were determined by ELISA assays. Two biopsy specimens from the antrum and gastric body were taken for standard histological analyses and rapid urease test. A pathologist examined the biopsy specimens of patients blindly. Results: A total of 153 patients with indigestion (62.7% female; mean age, 63.7 years; 37.3% male; mean age, 64.9 years) were included in this study. The G17 levels significantly increased in patients with chronic atrophic gastritis (CAG) of the body (9.7 vs. 32.8 pmol/L; P = 0.04) and reduced in patients with antral CAG (1.8 vs. 29.1 pmol/L; P = 0.01). The results were acceptable for all three types of CAG, including the antral, body, and multifocal CAG (AUCs of 97%, 91%, and 88% for body, antral, and multifocal CAG, respectively). The difference in PGII level was not significant. Also, the PGI and PGI/PGII ratio did not show a significant difference (unacceptably low AUCs for all). The H. pylori antibody levels were higher in patients infected with H. pylori (251 EIU vs. 109 EIU, AUC = 70, P = 0.01). There was a significant relationship between antibody tests and histopathology. Conclusion: Contrary to Biohit's claims, the GastroPanel kit is not accurate enough to detect CAG; therefore, it cannot be used for establishing a clinical diagnosis.
Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer

Meiping Xiao,Zhiying Zhang,Guanghong Liao,Min Liu,Xuehong Chen

DOI: https://doi.org/10.14715/cmb/2022.68.8.20

2022-08-31

Abstract:To explore the value of the Helicobacter pylori test in combination with the determination of plasma pepsinogen (PG) and gastrin 17 in screening the precancerous status of gastric cancer and gastric cancer in the healthy population, between 2019 and 2022, we enrolled a total of 402 subjects who went to the physical examination in the Center of Health Management of Ganzhou people's Hospital and additionally underwent the urea (14C) breath test and determination of PGI, PGII and G-17. Anomalies in Hp, PG or G-17 ≥ 2, or a single anomaly in PG determination would be taken as positive, and the diagnosis should be further confirmed by the gastroscopy and pathological test. According to the results, subjects would be further divided into the gastric cancer group, precancerous lesion group, precancerous disease group and control group, aiming to clarify the relationship between Hp, PG and G-17 levels and the precancerous status and development of gastric cancer and the screening value. Results showed that Hp-positive infection was found in 341 subjects (84.82%). Hp infection rate in the control group was much lower than those in the precancerous disease group, precancerous lesion group and gastric cancer group (P < 0.05). The CagA positive rates in the gastric cancer group and precancerous lesion group were significantly higher than those in the precancerous disease group and control group, while the serum level of G-17 in the gastric cancer group was much higher than those in the precancerous lesion group, precancerous disease group and control group (P < 0.05), and the PG I/II ratio in the gastric cancer patients was also lower than those in the precancerous lesion group, precancerous disease group and control group (P < 0.05). As the disease progressed, the G-17 level also increased but PG I/II ratio decreased gradually (P < 0.001). Hp test in combination with PG and G-17 shows a high value in determining the precancerous status of gastric cancer and screening for gastric cancer in healthy subjects.
A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection

Hajime Teshima,Hidehiko Takigawa,Takahiro Kotachi,Akiyoshi Tsuboi,Hidenori Tanaka,Ken Yamashita,Yoshihiro Kishida,Yuji Urabe,Toshio Kuwai,Akira Ishikawa,Shiro Oka

DOI: https://doi.org/10.3390/jcm13216599

IF: 3.9

2024-11-04

Journal of Clinical Medicine

Abstract:Background and Objective: Serum markers such as gastrin and pepsinogen are useful for stratifying gastric cancer risk. However, their utility in predicting metachronous gastric cancer after endoscopic submucosal dissection (ESD) in patients with gastric cancer after Helicobacter pylori eradication (GCAE) is unclear. This study aimed to clarify predictive factors for metachronous gastric cancer after ESD with a focus on serum markers. Methods: A retrospective analysis was conducted on 197 patients with 224 GCAE lesions who underwent ESD at Hiroshima University Hospital between April 2010 and December 2019. In total, 63 patients with 74 differentiated-type lesions were classified into metachronous gastric cancer (MG) and non-metachronous gastric cancer (NMG) groups, excluding proton pump inhibitor (PPI) users, female patients, and undifferentiated-type cases. The predictive value of serum markers was assessed using ROC curve analysis, and their association with carcinogenesis was evaluated using multiple logistic regression. Furthermore, the incidence of MG was compared between long-term PPI users and non-users. Results: ROC analysis revealed that serum gastrin had the highest discriminative ability for MG (AUC 0.77, cut-off 99 pg/mL, sensitivity 61.6%, and specificity 80.0%). Severe mucosal atrophy and high gastrin levels were significantly more common in the MG group and were independent predictors (p < 0.01). Although serum gastrin levels were significantly elevated in PPI users, no increased risk of MG was observed. Conclusions: In addition to severe mucosal atrophy, PPI-independent elevated serum gastrin levels may be associated with an increased risk of MG after ESD. Serum gastrin may serve as a valuable marker for post-ESD cancer surveillance in GCAE patients.

medicine, general & internal
Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

L Zhang,WJ Blot,WC You,YS Chang,RW Kneller,ML Jin,JY Li,L Zhao,WD Liu,JS Zhang,JL Ma,IM Samloff,P Correa,MJ Blaser,GW Xu,JF Fraumeni

1996-01-01

Abstract:Helicobacter pylori infection is a major cause of gastritis and may be a key risk factor for stomach cancer, but its role in the process of gastric carcinogenesis is not well understood. Herein, we examine H. pylori prevalence in relation to demographic and lifestyle factors and to severity of precancerous lesions in an area of China with one of the highest rates of stomach cancer in the world. H. pylori serum IgG antibody positivity was assayed among 2646 adults, ages 35-64, participating in a population-based gastroscopic screening survey in the high-risk area. The prevalence of positivity was evaluated according to gastric histology, environmental and lifestyle variables determined by interviews during the screening, and level of serum pepsinogens. The odds of advanced precancerous lesions (intestinal metaplasia and dysplasia) of the stomach among those with antibody positivity were estimated by logistic regression. Seventy-two % of the population was H. pylori antibody-positive, with nonsignificant variation by sex, age, income, education, family size, and cigarette smoking habits. H. pylori positivity was higher among those who ate sour pancakes, a fermented indigenous staple that is a risk factor for gastric dysplasia and stomach cancer in this population. The prevalence of H. pylori varied most notably, however, with gastric pathology. The percent of H. pylori positivity increased from 55 to 60 to 87% among those with superficial (nonatrophic) gastritis, mild chronic atrophic gastritis, and severe chronic atrophic gastritis, respectively, before falling to 78% among those with intestinal metaplasia or dysplasia. H. pylori antibody positivity also was strongly correlated with serum pepsinogen concentrations, particularly pepsinogen II, but knowledge of H. pylori status did not markedly improve serological identification of advanced precancerous lesions above that provided by pepsinogen ratios alone. The findings suggest that H. pylori infection contributes to the process of gastric carcinogenesis, particularly during the early stages, in this high-risk area.
Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study

Yuling Tong,Hongguang Wang,Yi Zhao,Xueqiang He,Hongwei Xu,Hong Li,Ping Shuai,Lirong Gong,Hongbo Wu,Hongzhi Xu,Yinhu Luo,Dong Wang,Shizhu Liu,Zhenya Song

DOI: https://doi.org/10.3389/fonc.2021.652574

IF: 4.7

2021-08-24

Frontiers in Oncology

Abstract:Background Pepsinogens (PGs) can be used for gastric cancer (GC) screening, but the cutoff levels vary among studies, and PG levels are influenced by numerous factors. The aim of this article is to examine the diagnostic value of PG levels and Helicobacter pylori (Hp) status for GC and atrophic gastritis screening in asymptomatic individuals undergoing health checkup in China. Patients and Methods This was a multicenter cross-sectional study of subjects who underwent health checkup from 10/2016 to 10/2018 at nine International Healthcare Centers in China. All participants underwent gastroscopy and pathological examination, serum PG, 13 C-urea breath test, and/or Hp serological current infection marker rapid test, all on the same day. PG-related parameters were analyzed in different Hp subgroups and regions. Results The patients were grouped as non-atrophic (NAG, n = 1,590), mild to moderate atrophic (MAG, n = 273), severe atrophic (SAG, n = 49), and GC (n = 10). The serum PG levels in these groups decreased with increasing pathological severity. In the same pathological groups, PGI and PGII levels were higher in the Hp -positive subgroup, while PGR (PGI/PGII ratio) was lower (P < 0.05). The best cutoff values for atrophy diagnosis were PGI ≤73.1 ng/ml and PGR ≤9.8, for severe atrophy were PGI ≤63.9 ng/ml and PGR ≤9.09, and for GC was PGR ≤4.7 (all P < 0.05 and area under the curve >0.7). The cutoff points varied with Hp status and China regions. Conclusion Serum PG levels might be used for the screening of gastric atrophic gastritis lesions. The results suggest that different cutoff values should possibly be used in different Hp status groups and geographical regions, but it will have to be validated in future studies. Future studies should also examine the value of PG levels for GC detection.

oncology
Identification of serologically active Helicobacter pylori antigens related to alterations in serum pepsinogen levels

Rodolfo González Segovia,Yolanda Romo Lozano,Martín Gerardo Rodríguez,Angelina Lizbeth Montañez Flores,Juan González Macías

DOI: https://doi.org/10.1016/j.ram.2023.04.003

Abstract:Gastric adenocarcinoma is associated with Helicobacter pylori infection. The transition to a carcinogenic process is preceded by glandular atrophy and serum levels of pepsinogen I and II (PGI and PGII) correlate with this type of gastric lesions. Possible associations of serum PG levels in relation to the frequency of serological activity against H. pylori antigens were studied. Serum samples from patients with gastric pathology associated with H. pylori (n=26) and asymptomatic individuals as controls (n=37) were used. Seroactive antigens were identified by immunoblot using a protein extract of H. pylori. The antibody titers anti-H. pylori and the concentration of PGs in serum was determined by ELISA. Thirty-one seroactive antigens were identified, nine of which exhibited a differential frequency between both groups (116.7, 68.8, 61.9, 54.9, 45.6, 38.3, 36.5, 33.8 and 30.1kDa) and only 3 were related to altered levels of PGs in serum. In the control group, the seropositivity of the 33.8kDa antigen was related to an increase in PGII, while the 68.8kDa antigen was related to normal PG values (decreased PGII and elevated PGI/PGII levels) indicating that seropositivity to this antigen could be a protective factor to gastric pathology. The seropositivity of the 54.9kDa antigen was related to altered values of PGs indicative of inflammation and gastric atrophy (increased in PGII and decreased in PGI/PGII). The identification of serum alterations in pepsinogen levels related to seropositivity to H. pylori 33.8, 54.9 and 68.8kDa antigens sets a precedent for further study as possible prognostic serological biomarkers.
Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis

Zengyun Qiao,Enbo Wang,Boyang Bao,Xiaodong Tan,Liu Yuan,Dong Wang

DOI: https://doi.org/10.1097/meg.0000000000002765

2024-03-19

European Journal of Gastroenterology & Hepatology

Abstract:The objective of this meta-analysis is to delineate the association between H. pylori CagA serological status and the prevalence of gastric precancerous lesions (GPL). We searched peer-reviewed articles up to October 2023. The extraction of data from the included studies was carried out as well as the quality assessment. Pooled effect sizes were calculated using a random effect model. Thirteen studies met the inclusion criteria, comprising 2728 patients with GPL and 17 612 controls. The aggregate odds ratio (OR) for the association between serum CagA and GPL was 2.74 (95% CI = 2.25–3.32; P = 0.00; I2 = 60.4%), irrespective of H. pylori infection status. Within the H. pylori -infected cohort, the OR was 2.25 (95% CI = 1.99–2.56; P = 0.00; I2 = 0.0%). Conversely, among the non-infected individuals, the OR was 1.63 (95% CI = 1.04–2.54; P = 0.038; I2 = 0.0%). Heterogeneity was explored using subgroup and meta-regression analyses, indicating that the variability between studies likely stemmed from differences in disease classification. Our results demonstrated robustness and negligible publication bias. The meta-analysis underscores a more pronounced association between H. pylori CagA seropositivity and the risk of developing GPL than between seronegativity and the same risk, irrespective of H. pylori infection status at the time. Additionally, the strength of the association was heightened in the presence of an active H. pylori infection. The implications of these findings advocate for the utility of CagA serostatus as a potential biomarker for screening GPL.

gastroenterology & hepatology

Human genome project. Variation is now the theme.

Relative Risk of Gastric Cancer Between Those with and Without Helicobacter Pylori Infection History in Japan

A novel predictive formula for highly accurate discrimination between truly Helicobacter pylori-uninfected and currently infected/spontaneously eradicated individuals for gastric cancer screening

[Serological Assessment of Helicobacter Pylori-Specific Antibodies and Their Association with Gastric Lesions in a High-Risk Population].

Endoscopic and Pathological Characteristics of Helicobacter pylori Infection-Negative Early Gastric Cancer

Fourier Analysis of Boolean functions and Discrete Isoperimetry

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection

Serum pepsinogens can help to discriminate between H. pylori-induced and auto-immune atrophic gastritis: Results from a prospective multicenter study

Clinical trial of glycodiazine--a new oral hypoglycemic drug.

A simple hygrometer for the measurement of evaporative loss from rodent skin.

Determination of serum pepsinogens levels in elderly patients with chronic gastritis and its significance

Abstract C13: Population-based Evaluation of Serum Pepsinogen, Anti-H. Pylori IgG Antibody and Gastrin-17 Tests for Gastric Cancer Screening

Non-parallel coevolution of sender and receiver in the acoustic communication system of treefrogs

Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection

Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer

A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study

Identification of serologically active Helicobacter pylori antigens related to alterations in serum pepsinogen levels

Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis